» Articles » PMID: 17469942

Moderate Drug Use and Delay Discounting: a Comparison of Heavy, Light, and Never Smokers

Overview
Specialty Pharmacology
Date 2007 May 2
PMID 17469942
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

Delay discounting was examined in light smokers (10 or fewer cigarettes per day) and compared with previously published delay discounting data for heavy and never smokers. Participants evaluated several hypothetical outcomes: money gains and loses ($10, $100, and $1,000), health gains and losses (durations of improved and impoverished health subjectively equivalent to $1,000), cigarette gains and losses (amounts subjectively equivalent to $1,000), and potentially real rewards ($10 and $100). Light smokers discounted money significantly more than never smokers, but light smokers did not differ from heavy smokers. The 3 groups did not statistically differ in discounting of health consequences. Similarly, the 2 smoking groups were not found to differ in discounting of cigarettes. Like heavy smokers, light smokers discounted cigarettes significantly more than money and health. Several significant, positive correlations were found between smoking rate and various discounting measures in the heavy smokers but not in the light smokers. Several previous findings were replicated, helping to validate the present results: the sign effect (greater discounting of gains than losses), the magnitude effect (greater discounting of smaller rewards), reliability of discounting measures over time, and the consistency of hypothetical and potentially real rewards. These data suggest that even moderate levels of drug use may be associated with high delay discounting levels.

Citing Articles

Whether temporal discounting is domain-specific between health outcomes and money: a systematic review and meta-analysis.

Tao T, Du J, Sun Y, Li X, Chen P Int J Clin Pharm. 2024; 47(1):31-45.

PMID: 39718761 DOI: 10.1007/s11096-024-01846-3.


The phenotype of recovery XII: A reinforcer pathology perspective on associations between delay discounting and pain catastrophizing in substance use disorder recovery.

Dwyer C, Craft W, Yeh Y, Cabral D, Athamneh L, Tegge A J Subst Use Addict Treat. 2024; 169:209573.

PMID: 39522768 PMC: 11801409. DOI: 10.1016/j.josat.2024.209573.


Aberrant neural computation of social controllability in nicotine-dependent humans.

McLaughlin C, Fu Q, Na S, Heflin M, Chung D, Fiore V Commun Biol. 2024; 7(1):988.

PMID: 39143128 PMC: 11324891. DOI: 10.1038/s42003-024-06638-z.


The Use of Nonmonetary Outcomes in Health-Related Delay Discounting Research: Review and Recommendations.

Rasmussen E, Camp L, Lawyer S Perspect Behav Sci. 2024; 47(2):523-558.

PMID: 39099748 PMC: 11294320. DOI: 10.1007/s40614-024-00403-7.


Recent Experience Affects Delay Discounting: Evidence across Temporal Framing, Signs, and Magnitudes.

Willis-Moore M, Haynes J, Frye C, Johnson H, Cousins D, Bamfo H Perspect Behav Sci. 2024; 47(2):365-392.

PMID: 39099743 PMC: 11294302. DOI: 10.1007/s40614-024-00412-6.